We offer a full range of products and support services.
DSG Designer lets the user be the creator with complete control of workflow to help streamline trial execution. DSG’s unparalleled support services and hands-on training ensure that you build studies end-to-end. We help you create reusable templates and eCRFs that can lower your cost to deliver a completed study for regulatory approval.
eCaseLink is an award winning web based EDC software application that enables the most advanced clinical data collection while still providing an easy-to-use, user-friendly presentation of eCRFs. eCaseLink provides the fastest start up, rapid database lock, and more rapid FDA submissions, resulting in greater ROI.
DSG’s award winning IWRS (Interactive Web Response System) is a seamlessly integrated component of eCaseLink that helps you to easily manage randomization, subject enrollment and drug supply management in any clinical trial.
eCaseLink, DSG’s web based Clinical Trial Management System (CTMS), is a project management application that helps you to capture and share a wide variety of clinical trial project status information across multiple studies. eClinDirect gives you unparalleled control over your clinical trial study.
The Drug Safety system enables medical monitors to electronically record the SAE form information received from a site. Enter data into forms manually, as well as prefill certain fields mapped from the eCaseLink EDC system. Key events, dates and status are all easily tracked. The Drug Safety system alerts the medical monitor to differences between the safety data entry form and the data entered into eCRFs within the eCaseLink EDC system.
eCaseLink.Me provides a flexible approach to patient-reported data capture that can be used alone or in combination with eCaseLink EDC software for reporting and data analysis. Designed with the patient in mind, eCaseLink.Me allows patients to personalize and change the appearance of the application to better suit preferences. It works on any browser or web-enabled device.